Revised GH and cortisol cut-points for the glucagon stimulation test in the evaluation of GH and hypothalamic-pituitary-adrenal axes in adults: results from a prospective randomized multicenter study
The DOI matches its Crossref record; 35 of the 35 references it cites were found in a registry or an index.
Abstract
Context Recent studies suggest using lower GH cut-points for the glucagon stimulation test (GST) in diagnosing adult GH deficiency (GHD), especially in obese patients. There are limited data on evaluating GH and hypothalamic-pituitary-adrenal (HPA) axes using weight-based dosing for the GST. Objective To define GH and cortisol cut-points to diagnose adult GHD and secondary adrenal insufficiency (SAI) using the GST, and to compare fixed-dose (FD: 1 or 1.5 mg in patients >90 kg) with weight-based dosing (WB: 0.03 mg/kg). Response to the insulin tolerance test (ITT) was considered the gold standard, using GH and cortisol cut-points of ≥3 ng/ml and ≥18 µg/dL, respectively. Design 28 Patients with hypothalamic-pituitary disease and 1-2 (n = 14) or ≥3 (n = 14) pituitary hormone deficiencies, and 14 control subjects matched for age, sex, estrogen status and body mass index (BMI) underwent the ITT, FD- and WB-GST in random order. Results Age, sex ratio and BMI were comparable between the three groups. The best GH cut-point for diagnosis of GHD was 1.0 (92 % sensitivity, 100 % specificity) and 2.0 ng/mL (96 % sensitivity and 100 % specificity) for FD- and WB-GST, respectively. Age negatively correlated with peak GH during FD-GST (r = -0.32, P = 0.04), but not WB-GST. The best cortisol cut-point for diagnosis of SAI was 8.8 µg/dL (92 % sensitivity, 100 % specificity) and 11.2 µg/dL (92 % sensitivity and 100 % specificity) for FD-GST and WB-GST, respectively. Nausea was the most common…
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Citations
Cites
Molitch, M. E., Clemmons, D. R., Malozowski, S., Merriam, G. R., & Vance, M. L. (2011) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2011-0179 · Cited by 1,047
Ho, K. K. Y., & _, _. (2007) · European Journal of Endocrinology · doi:10.1530/eje-07-0631 · Cited by 615
Molitch, M. E., Clemmons, D. R., Malozowski, S., Merriam, G. R., Shalet, S. M., Vance, M. L., & for The Endocrine Society’s Clinical Guidelines Subcommittee (2006) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2005-2227 · Cited by 424 · cited 1×
“0 ng/mL to define severe GH deficiency [6].”
BackgroundWhich Patients Do Not Require a GH Stimulation Test for the Diagnosis of Adult GH Deficiency?
Hartman, M. L. (2002) · Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.87.2.477 · Cited by 319 · cited 1×
“Current published guidelines recommend evaluation of adult GH deficiency (GHD) in the appropriate clinical context through GH provocative testing [1, 2], with the exception of patients with three or more pituitary hormone deficiencies (PHD) and a low serum IGF-I level, where no further biochemical testing is needed [3…”
BackgroundSelf-citationCorneli, G., Di Somma, C., Baldelli, R., Rovere, S., Gasco, V., Croce, C. G., Grottoli, S., Maccario, M., Colao, A., Lombardi, G., et al. (2005) · European Journal of Endocrinology · doi:10.1530/eje.1.01967 · Cited by 317 · cited 1×
“Based on the current literature, it is plausible to suggest that patients with higher BMI tend to achieve lower peak GH levels during GST, however, our study was not sufficiently powered to propose specific GH cut-points for normal, overweight and obese patients [26].”
BackgroundNeuroendocrine dysfunction in the acute phase of traumatic brain injury
Agha, A., Rogers, B., Mylotte, D., Taleb, F., Tormey, W., Phillips, J., & Thompson, C. J. (2004) · Clinical Endocrinology · doi:10.1111/j.1365-2265.2004.02023.x · Cited by 313 · cited 1×
“In the majority of the previous studies, a higher cortisol level is achieved during ITT and standard ACTH stimulation test compared to GST [14, 17, 20, 23, 27].”
ResultCook, D. M., Yuen, K. C. J., Biller, B. M. K., Kemp, S. F., Vance, M. L., Cook, D. M., Yuen, K. C. J., Biller, B. M. K., Kemp, S. F., Vance, M. L., et al. (2009) · Endocrine Practice · doi:10.4158/ep.15.s2.1 · Cited by 179
Self-citationPokrajac, A., Wark, G., Ellis, A. R., Wear, J., Wieringa, G. E., & Trainer, P. J. (2007) · Clinical Endocrinology · doi:10.1111/j.1365-2265.2007.02836.x · Cited by 172 · cited 1×
“Accordingly, method-specific cut-off levels for dynamic tests might be necessary to correctly interpret and compare results from different laboratories [33, 35].”
BackgroundLeong, K. S., Walker, A. B., Martin, I., Wile, D., Wilding, J., & MacFarlane, I. A. (2001) · Clinical Endocrinology · doi:10.1046/j.1365-2265.2001.01169.x · Cited by 140 · cited 1×
“[16] suggested that the GST could be shortened by omitting the 240-min blood sample.”
BackgroundGrowth hormone release after glucagon as a reliable test of growth hormone assessment in adults
Gómez, J. M., Espadero, R. M., Escobar‐Jiménez, F., Hawkins, F., Picó, A., Herrera‐Pombo, J. L., Vilardell, E., Durán, A., Mesa, J., Faure, E., et al. (2002) · Clinical Endocrinology · doi:10.1046/j.1365-2265.2002.01472.x · Cited by 130 · cited 3×
“There are a number of possible reasons for the discrepancies between earlier and recent studies [1, 8, 9].”
BackgroundResult
Cited by
Hormonal Replacement in Hypopituitarism in Adults: An Endocrine Society Clinical Practice Guideline
Fleseriu, M., Hashim, I. A., Karavitaki, N., Melmed, S., Murad, M. H., Salvatori, R., & Samuels, M. H. (2016) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2016-2118 · Cited by 945
Yuen, K. C. J., Biller, B. M. K., Radovick, S., Carmichael, J. D., Jasim, S., Pantalone, K. M., & Hoffman, A. R. (2019) · Endocrine Practice · doi:10.4158/gl-2019-0405 · Cited by 298
Self-citationSklar, C. A., Antal, Z., Chemaitilly, W., Cohen, L. E., Follin, C., Meacham, L. R., & Murad, M. H. (2018) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2018-01175 · Cited by 224
Hahner, S., Ross, R. J., Arlt, W., Bancos, I., Burger-Stritt, S., Torpy, D. J., Husebye, E. S., & Quinkler, M. (2021) · Nature Reviews Disease Primers · doi:10.1038/s41572-021-00252-7 · Cited by 223
Pathogenesis and Diagnosis of Growth Hormone Deficiency in Adults
Melmed, S. (2019) · New England Journal of Medicine · doi:10.1056/nejmra1817346 · Cited by 173
Metadata
- Authors
- Hamrahian, A. H., Yuen, K. C. J., Gordon, M. B., Pulaski-Liebert, K. J., Bena, J., & Biller, B. M. K.
- Affiliations
- Cleveland Clinic (US)
- Swedish Medical Center (US)
- Allegheny General Hospital (US)
- Cleveland Clinic Research (US)
- Massachusetts General Hospital (US)
- Corresponding author
- Hamrahian, Amir H.
- Venue
- Pituitary
- Published
- 2016-02-20
- Volume
- 19
- Issue
- 3
- Pages
- 332-341
- ISSN
- 1386-341X (ISSN-L)
- 1573-7403
- OpenAlex
- W2277973416
- Semantic Scholar
- 3994d9fde59d27c9a3399f08c5287fa55d84a8de
- Cited by
- 92
- References
- 35
- Citations by year
- 2026: 4 · 2025: 5 · 2024: 14 · 2023: 6 · 2022: 10 · 2021: 7 · 2020: 11 · 2019: 9 · 2018: 9 · 2017: 11 · 2016: 5
- FWCI
- 11.38
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.springer.com/tdm (tdm)
- Locations
- Pituitary (publishedVersion)
- PubMed (publishedVersion)
- Funders
- Novo Nordisk (IIS-000160)
- Topics
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Growth Hormone and Insulin-like Growth Factors
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Pituitary Gland Disorders and Treatments
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Adrenal Hormones and Disorders
- Keywords
- glucagon stimulation test, adult growth hormone deficiency, secondary adrenal insufficiency, weight-based dosing, insulin tolerance test, hypothalamic-pituitary-adrenal axis, pituitary hormone deficiency, obesity, sensitivity and specificity, seizure risk, pituitary adenoma, pituitary apoplexy
- MeSH terms
- Adenoma, Adrenal Insufficiency, Adult, Aged, Blood Glucose, Body Weight, Cosyntropin, Craniopharyngioma, Dose-Response Relationship, Drug, Female, Glucagon, Hormones, Humans, Hydrocortisone, Hypoglycemic Agents, Hypopituitarism, Hypothalamo-Hypophyseal System, Insulin, Male, Middle Aged, Pituitary Neoplasms, Pituitary-Adrenal System, Reference Values, Sensitivity and Specificity, Case-Control Studies, Human Growth Hormone, Central Nervous System Cysts
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Revised GH and cortisol cut-points for the glucagon stimulation test in the evaluation of GH and hypothalamic-pituitary-adrenal axes in adults: results from a prospective randomized multicenter study. https://app.cochat.ai/papers/10.1007/s11102-016-0712-7
- The paper
- Hamrahian, A. H., Yuen, K. C. J., Gordon, M. B., Pulaski-Liebert, K. J., Bena, J., & Biller, B. M. K. (2016). Revised GH and cortisol cut-points for the glucagon stimulation test in the evaluation of GH and hypothalamic-pituitary-adrenal axes in adults: results from a prospective randomized multicenter study. Pituitary. https://doi.org/10.1007/s11102-016-0712-7
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.